[11C]GSK-1838705-A

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug Name[11C]GSK-1838705-A
Drug Alias Name[11C]GSK-1838705-A[11C]GSK-1838705A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor antagonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDba Winston-Salem Comprehensive Treatment Center
China Registration ClassN/A

Develop Information

Active CompaniesDba Winston-Salem Comprehensive Treatment Center
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A